Alyssa Capel

Researchers determined the real-world incidence of acute gout prophylaxis (AGP) while prescribing a xanthine oxidase inhibitor, and described the characteristics of AGP prescribing in reducing gout flares.

Researchers assessed whether febuxostat increased the risk of developing cardiovascular events, death from cardiac-cause, and all-cause mortalities.